Britta Vormoor

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Linde Dekker, Friso Calkoen, Yilin Jiang et al. · Blood Advances · 2022 · 85 citations · Full text

Medicine, Hematology, Pharmacology +16

CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study

Elad Jacoby, Sara Ghorashian, Britta Vormoor et al. · Leukemia · 2022 · 65 citations

Medicine, Oncology, Pediatrics +17

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

Jordy C.G. van der Zwet, Jessica G. C. A. M. Buijs-Gladdines, Valentina Cordo’ et al. · Leukemia · 2021 · 48 citations

Medicine, Cancer Biology, Oncology +15

Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging

Britta Vormoor, Henrike K. Knizia, Michael A. Batey et al. · PLoS ONE · 2014 · 43 citations · Full text

Medicine, Oncology, Pathology +17

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

Britta Vormoor, Gareth J. Veal, Martin J. Griffin et al. · Pediatric Blood & Cancer · 2016 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15